騰訊(00700.HK)與交通銀行(03328.HK)簽署企業支付合作協議
騰訊(00700.HK)公布,近日與交通銀行(03328.HK)簽署企業支付合作協議,在產業金融領域達成合作,交通銀行成為騰訊金融科技旗下商企付平台銀企支付產品的首家合作銀行,雙方並將在鋼貿、化工、有色等方面為企業提供高效、便捷的支付及企業金融方案,推動產業數字化升級。
雙方將合作令銀企支付產品與交通銀行交e保產品能力互通,料可提升企業在產業互聯網場景中的支付效率。騰訊金融科技旗下企業級支付平台「商企付」,將為產業互聯網提供安全、專業、高效的支付解決方案,平台的銀企支付產品,在不改變買賣雙方收付款賬號和轉賬習慣的前提下,協助企業實現信息流、物流和資金流合一。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.